View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
THURSDAY, April 8 (HealthDay News) -- Balloon expandable drug-eluting stents (DES) are effective and safe in preventing major amputation and relieving symptoms in patients with below-the-knee critical leg ischemia, according to a study published in the April 13 issue of the Journal of the American College of Cardiology.
Andrew Feiring, M.D., of Columbia-St. Mary's Medical Center in Milwaukee, Wis., and colleagues treated 106 patients (118 limbs) with DES in a prospective, non-randomized trial.
There were no procedural deaths, and 96 percent of the patients were discharged within 24 hours. The researchers found that the three-year cumulative incidence of amputation was 6 percent ± 2 percent, survival was 71 percent ± 5 percent, and amputation-free-survival was 68 percent ± 5 percent. Also, only 12 percent of patients who died had a previous major amputation. The target limb revascularization rate was 15 percent.
"Treating below-the-knee critical limb ischemia with DES appears to be a safe and effective means of preventing major amputations and relieving symptoms. Procedural complications and revascularizations were low. Patients treated with DES have significantly fewer major amputations and higher survival rates than historic controls," the authors write.
One author disclosed serving as a consultant for Cordis, Johnson & Johnson.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top